Skip to content

Application of Near Infrared-Indocyanine Green Imaging System in Robot/Laparoscopic Colorectal Cancer Surgery: A Single Center, Prospective Controlled Trial

Application of Near Infrared-Indocyanine Green Imaging System in Robot/Laparoscopic Colorectal Cancer Surgery: A Single Center, Prospective Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025753
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Control group:Not use near infrared-indocyanine green imaging system

Sponsors

Army Medical Center of PLA (Daping Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years at the time of diagnosis; 2. Diagnosis of colorectal carcinoma and was confirmed by preoperative pathology; 3. MRI was performed before operation, patients with right colon cancer; 4. The colon-rectum or colon-anus anastomosis was performed by laparoscopic TME operation; 5. The "spleen area" was not free during the operation; 6. Baseline clinical tumor stage TNM I-III phase cT1-4N0-2M0 (AJCC-8 version).

Exclusion criteria

Exclusion criteria: 1. Allergic to ICG or iodine; 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding who need emergency operation; 3. Patients requiring combined organ resection that the tumor involves adjacent organs; 4. Patients with recurrence of tumor or distant metastasis; 5. Patients with multiple colorectal cancer; 6. Patients with history of inflammatory bowel disease or familial adenomatous polyposis; 7. Patients who have participated in or are participating in other clinical trials in the past four weeks; 8. Patients that ASA level is larger than III; 9. Physical condition: Patients with KPS less than or equal to 60 points or ECOG larger than or equal to 2 points; 10. Patients with hepatic dysfunction and MELD larger than 12 points; 11. Patients with a history of serious mental illness; 12. Pregnant or lactating women; 13. Patients who are improper to participate in the study in the opinion of the researchers.

Design outcomes

Primary

MeasureTime frame
Number of lymph nodes detected and positive rate;Perfusion of anastomosis;Anastomotic leakage;Navigation of vessels and structures;

Secondary

MeasureTime frame
Average length of stay after operation;2?????? 2-year local recurrence rate;Progress Free Survival;Overall Survival;

Countries

China

Contacts

Public ContactFan Li

Army Medical Center of PLA (Daping Hospital)

levinecq@163.com+86 18696539200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026